Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies
Letters in Drug Design & Discovery · 2025-11 · 22 (11) · 100269
DOI: 10.1016/j.lddd.2025.100269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2025-11. Verfasst von Adnan Cetin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yüzüncü Yil Üniversitesi, Bilimsel Araştırma Projeleri Birimi, İstanbul Teknik Üniversitesi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Yüzüncü Yil Üniversitesi
- Bilimsel Araştırma Projeleri Birimi, İstanbul Teknik Üniversitesi
Zitieren
APA
Cetin, A., Türkan, F., Oğuz, E., Rozbicki, P., Wolińska, E., & Branowska, D. (2025). Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies. Letters in Drug Design & Discovery, 22(11), 100269. https://doi.org/10.1016/j.lddd.2025.100269
Vancouver
Cetin A, Türkan F, Oğuz E, Rozbicki P, Wolińska E, Branowska D. Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies. Letters in Drug Design & Discovery. 2025;22(11):100269. doi:10.1016/j.lddd.2025.100269
BibTeX
@article{Cetin2025,
author = {Cetin, Adnan and Türkan, Fikret and Oğuz, Ercan and Rozbicki, Przemysław and Wolińska, Ewa and Branowska, Danuta},
title = {Substituted bipyridine-based compounds: Synthesis, enzyme inhibition, anticancer activities and molecular docking studies},
journal = {Letters in Drug Design & Discovery},
year = {2025},
volume = {22},
number = {11},
pages = {100269},
doi = {10.1016/j.lddd.2025.100269}
}
EUVIMED